Samsung, through its US digital radiography and ultrasound business Boston Imaging, has introduced the new V6 ultrasound system to address the clinical needs of Women’s Health and Urology.
Boston Imaging said the new ultrasound system will combine image clarity and advanced automated features to deliver complete imaging capabilities in 2D, 3D and colour image quality.
The ultrasound system enhances image clarity and accuracy and can be used in various settings based on its remote access, simple workflows, wide-screen and compact design with a battery option.
The V6 ultrasound system has recently received the US Food and Drug Administration (FDA) 510(k) approval for commercial use.
It is designed to be budget-friendly while meeting workflow and productivity needs, said the medical device maker.
Boston Imaging said the V6 system has been evaluated for acoustic output, biocompatibility, software function, cleaning and disinfection effectiveness.
In addition, the system is being tested for thermal, electrical, electromagnetic, and mechanical safety, as per the applicable FDA guidance and medical device safety standards.
Boston Imaging head David Legg said: “We are thrilled to introduce our latest innovation in Women’s Health and Urology imaging, reflecting our unwavering commitment to delivering efficient care and meeting the imaging demands of medical professionals.”
Boston Imaging women’s health segment leader Tracy Bury said: “We’re proud to offer a new product that is not only accessible to a broad group of clinicians but also has innovative, automated features that can make patient care simpler and more efficient.”
The V6 ultrasound system is designed based on Samsung’s core imaging platform, dubbed Crystal Architecture, to offer both enhanced image clarity and advanced automated tools.
It includes a miniER7 Endocavity Transducer, which comes with a compact design for patient comfort, a 180° field of view for wide-angle imaging and a 2-12MHz frequency range.
The V6 system comprises ViewAssist, an artificial intelligence (AI) feature that automatically identifies imaging planes to simplify documentation and enhance exam workflow.
It features BiometryAssist, a semi-automated feature based on Deep Learning that enables foetal growth measurements to provide exam consistency while reducing keystrokes.
The system also features UterineAssist, an AI technology that automatically measures the size and shape of the uterus to help detect the signs of uterine-related abnormalities.
It can securely share the images using Mobile Export, which leverages a simple QR code to transfer foetal images from the ultrasound system directly to the patient’s smartphone.
V6 also uses the real-time image share solution, SonoSync, which facilitates communication for care guidance and training between doctors and sonographers.
Furthermore, V6 is compatible with Cycle Clarity’s AI-based software platform, which allows it to be used in the reproductive endocrinology and infertility setting.
